Bone Density of Newborn Infants to Mothers Treated With Selective Serotonin Reuptake Inhibitor (SSRI)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00818727

Enrollment

Registered

2009-01-08

Start date

2009-02-28

Completion date

Unknown

Last updated

2009-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Density

Keywords

Bone density, SSRI, newborn infants

Brief summary

SSRI treatment in adults was found to decrease bone density. The use of SSRI among pregnant women with depression or anxiety is extendent and raising. The effect of bone density of the infants was not yet evaluated.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Days to 7 Days

Healthy volunteers

Inclusion criteria

* Term newborn infants to mothers treated with SSRI and healthy controls

Exclusion criteria

* Preterms, major congenital malformations.

Design outcomes

Primary

Measure	Time frame
bone density	1 month

Outcome results